Elevated homocysteine is associated with increased rates of epigenetic aging in a population with mild cognitive impairment

Elevated homocysteine is associated with increased rates of epigenetic aging in a population with mild cognitive impairment

Elevated plasma total homocysteine (tHcy) is associated with the development of Alzheimer's disease and other forms of dementia. In this study, we report the relationship between tHcy and epigenetic age in older adults with mild cognitive impairment from the VITACOG study. Epigenetic age and ra...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Holmes, HE, Valentin, RE, Jernerén, F, de Jager Loots, CA, Refsum, H, Smith, AD, Guarente, L, Dellinger, RW, Sampson, D, Alzheimer's Disease Neuroimaging Initiative
Format:	Journal article
Język:	English
Wydane:	Wiley Open Access 2024

Podobne zapisy

CSF TNF α levels were associated with conversion from mild cognitive impairment to dementia.
od: Pan Fu, i wsp.
Wydane: (2022-01-01)

Random forest model for feature-based Alzheimer's disease conversion prediction from early mild cognitive impairment subjects.
od: Matthew Velazquez, i wsp.
Wydane: (2021-01-01)

Omega-3 Fatty Acid Status Enhances the Prevention of Cognitive Decline by B Vitamins in Mild Cognitive Impairment
od: Oulhaj, A, i wsp.
Wydane: (2016)

Early diagnosis of Alzheimer’s disease and mild cognitive impairment using MRI analysis and machine learning algorithms
od: Helia Givian, i wsp.
Wydane: (2024-12-01)

NeuropsychBrainAge: A biomarker for conversion from mild cognitive impairment to Alzheimer's disease
od: Jorge Garcia Condado, i wsp.
Wydane: (2023-10-01)

Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: a randomized controlled trial.
od: de Jager, C, i wsp.
Wydane: (2012)

Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: A randomized controlled trial
od: De Jager, C, i wsp.
Wydane: (2012)

The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease.
od: Luise Christine Löwe, i wsp.
Wydane: (2016-01-01)

Item-Level Scores on the Boston Naming Test as an Independent Predictor of Perirhinal Volume in Individuals with Mild Cognitive Impairment
od: Matteo De Marco, i wsp.
Wydane: (2023-05-01)

Uncovering heterogeneous cognitive trajectories in mild cognitive impairment: a data-driven approach
od: Xiwu Wang, i wsp.
Wydane: (2023-03-01)

Associations between Neuropsychiatric Symptoms and Alzheimer’s Disease Biomarkers in People with Mild Cognitive Impairment
od: Giulia Arenare, i wsp.
Wydane: (2023-08-01)

Choroid plexus volumes and auditory verbal learning scores are associated with conversion from mild cognitive impairment to Alzheimer's disease
od: Michael J. Pearson, i wsp.
Wydane: (2024-07-01)

BrainAGE in Mild Cognitive Impaired Patients: Predicting the Conversion to Alzheimer's Disease.
od: Christian Gaser, i wsp.
Wydane: (2013-01-01)

Serotonin enhances neurogenesis biomarkers, hippocampal volumes, and cognitive functions in Alzheimer’s disease
od: Ali Azargoonjahromi, i wsp.
Wydane: (2024-12-01)

Sleep and nighttime behavior disorders in older adults: associations with hypercholesterolemia and hypertriglyceridemia at baseline, and a predictive analysis of incident cases at 12 months follow-up
od: Asma Hallab, i wsp.
Wydane: (2024-09-01)

Brain Entropy Mapping in Healthy Aging and Alzheimer’s Disease
od: Ze Wang, i wsp.
Wydane: (2020-11-01)

Lower functional hippocampal redundancy in mild cognitive impairment
od: Stephanie Langella, i wsp.
Wydane: (2021-01-01)

FDG-PET hypermetabolism is associated with higher tau-PET in mild cognitive impairment at low amyloid-PET levels
od: Anna Rubinski, i wsp.
Wydane: (2020-10-01)

Elevated homocysteine and N-methyl-d-aspartate-receptor antibodies as a cause of behavioural and cognitive decline in 22q11.2 deletion syndrome.
od: Jones, S, i wsp.
Wydane: (2017)

Neurofilament light as a biomarker of axonal degeneration in patients with mild cognitive impairment and Alzheimer’s disease
od: Yi Chen, i wsp.
Wydane: (2021-12-01)

Abnormal cortical networks in mild cognitive impairment and Alzheimer's disease.
od: Zhijun Yao, i wsp.
Wydane: (2010-11-01)

Information Flow Pattern in Early Mild Cognitive Impairment Patients
od: Haijuan He, i wsp.
Wydane: (2021-11-01)

Alteration in temporal-cerebellar effective connectivity can effectively distinguish stable and progressive mild cognitive impairment
od: Chen Xue, i wsp.
Wydane: (2024-08-01)

Episodic memory network characteristics in patients with amnestic mild cognitive impairment accompanied by executive function impairment
od: Chao Wang, i wsp.
Wydane: (2024-06-01)

A longitudinal study of atrophy in amnestic mild cognitive impairment and normal aging revealed by cortical thickness.
od: Zhijun Yao, i wsp.
Wydane: (2012-01-01)

The Relationship Between Hippocampal Volumes and Delayed Recall Is Modified by APOE ε4 in Mild Cognitive Impairment
od: Xiwu Wang, i wsp.
Wydane: (2019-02-01)

Use of Deep-Learning Genomics to Discriminate Healthy Individuals from Those with Alzheimer’s Disease or Mild Cognitive Impairment
od: Lanlan Li, i wsp.
Wydane: (2021-01-01)

Predicting the Conversion from Mild Cognitive Impairment to Alzheimer’s Disease Using an Explainable AI Approach
od: Gerasimos Grammenos, i wsp.
Wydane: (2024-04-01)

Association of CSF GAP-43 and <i>APOE</i> ε4 with Cognition in Mild Cognitive Impairment and Alzheimer’s Disease
od: Yueli Zhu, i wsp.
Wydane: (2022-12-01)

Directed network motifs in Alzheimer's disease and mild cognitive impairment.
od: Eric J Friedman, i wsp.
Wydane: (2015-01-01)

The effect of plasma cortisol on hippocampal atrophy and clinical progression in mild cognitive impairment
od: Silke White, i wsp.
Wydane: (2023-07-01)

Deep multiview learning to identify imaging-driven subtypes in mild cognitive impairment
od: Yixue Feng, i wsp.
Wydane: (2022-09-01)

Brain network construction and analysis for patients with mild cognitive impairment and Alzheimer's disease based on a highly‐available nodes approach
od: Xiaopan Zhang, i wsp.
Wydane: (2021-03-01)

Detection of Alzheimer’s Disease Using Hybrid Meta-ROI of MRI Structural Images
od: Xiaoming Zheng, i wsp.
Wydane: (2024-10-01)

The personalized Alzheimer's disease cortical thickness index predicts likely pathology and clinical progression in mild cognitive impairment
od: Annie M. Racine, i wsp.
Wydane: (2018-01-01)

Homocysteine, B vitamins, and cognitive impairment
od: Smith, A, i wsp.
Wydane: (2016)

Homocysteine, B vitamins, and cardiovascular disease
od: Refsum, H, i wsp.
Wydane: (2006)

Homocysteine, B vitamins, and cardiovascular disease.
od: Refsum, H, i wsp.
Wydane: (2006)

Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial
od: Smith, A, i wsp.
Wydane: (2010)

Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial.
od: Smith, A, i wsp.
Wydane: (2010)